Salient Surgical Technologies Expands TRANSCOLLATION(R) Technology into Brain Tumor Resection Procedures to Provide Quick and Effective Hemostasis
PORTSMOUTH, N.H.--(BUSINESS WIRE)--As part of its continuing efforts to improve patient outcomes by reducing surgical blood loss, Salient Surgical Technologies, Inc. today announced the availability of its AQUAMANTYS® bipolar sealer product line to US surgeons for use in brain tumor resection procedures.